MedTrace Logo

Biomarkers of Mild and Moderate Traumatic Brain Injury

NCT01295346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2017-08-08

No results posted yet for this study

Summary

The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI. The assay will be evaluated in a sample population of subjects over the age of 18 who have been referred to the health care provider for closed head injury evaluation.

Conditions

  • Brain Injuries, Traumatic

Interventions

OTHER

Head CT scan and blood draw

Sponsors & Collaborators

  • Banyan Biomarkers, Inc

    lead INDUSTRY

Principal Investigators

  • Jackson Streeter, MD · Banyan Biomarkers

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States
  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01295346 on ClinicalTrials.gov